Effect of timely availability of TTR-stabilizing therapy on diagnosis, treatment initiation, and cardiovascular outcomes in transthyretin amyloid cardiomyopathy

Back

ESC Professional Premium Access

Effect of timely availability of TTR-stabilizing therapy on diagnosis, treatment initiation, and cardiovascular outcomes in transthyretin amyloid cardiomyopathy

Session: Heart failure phenotypes, diagnostics, and outcomes

Topic: Epidemiology, Prognosis, Outcome

Speaker: Doctor S. Dobner (Vienna, AT)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Stephan Dobner

Wilhelminen Hospital, Vienna (Austria)

0 follower

7 more presentations in this session

The impact of worsening heart failure (WHF) status on subsequent outcomes among patients with HFrEF: History of WHF events is associated with worse subsequent outcomes regardless of extent of GDMT

Speaker: Doctor L. Bash (Whitehouse Station, US) Doctor A. Stevenson (Chatham, US)

Prognostic value of NT-proBNP and cardiac troponin levels in ambulatory patients with congestive heart failure - Insight from NHANES.

Speaker: Doctor Y. Sattar (Morgantown, US)

Association between liver stiffness and congestive heart failure; analysis of the NHANES 2017 - 2020

Speaker: Doctor P. Wattanachayakul (Philadelphia, US)

Access

Abstract

Slides

Impact of cardiac power output, invasively measured by right heart catheterization, on exercise capacity and clinical outcomes in patients with chronic heart failure

Speaker: Doctor Y. Shimono (Sapporo, JP)

Prevalence of pulmonary hypertension in mitral regurgitation and its influence on outcomes

Speaker: Doctor S. Ratwatte (Sydney, AU)

Access the full session

Heart failure phenotypes, diagnostics, and outcomes

Speakers: Doctor S. Dobner, Doctor L. Bash, Doctor A. Stevenson, Doctor Y. Sattar, Doctor P. Wattanachayakul...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources